CAPSTONE INVESTMENT ADVISORS, LLC - ESPERION THERAPEUTICS INC NE ownership

Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$1,300,000
-25.3%
2,500,000
-28.6%
0.01%
-33.3%
Q2 2023$1,739,150
+23.9%
3,500,0000.0%0.01%
+28.6%
Q1 2023$1,403,850
-27.1%
3,500,0000.0%0.01%
-50.0%
Q4 2022$1,925,000
-2.3%
3,500,0000.0%0.01%
+16.7%
Q3 2022$1,971,000
+1.7%
3,500,0000.0%0.01%
+33.3%
Q2 2022$1,938,000
+7.4%
3,500,0000.0%0.01%
+80.0%
Q1 2022$1,805,000
-2.2%
3,500,0000.0%0.01%
+66.7%
Q4 2021$1,846,0003,500,0000.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2023
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 29,679,000$23,720,0007.42%
SILVERBACK ASSET MANAGEMENT LLC 11,750,000$6,487,1750.92%
DCF Advisers, LLC 1,550,000$884,0000.57%
Context Capital Management, LLC 14,764$8,274,0000.56%
AGF Investments LLC 7,000,000$3,872,0000.36%
WHITEBOX ADVISORS LLC 19,600,000$10,682,0000.30%
Pentwater Capital Management LP 46,411,000$26,134,0000.29%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$11,591,0000.27%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 24,000,000$13,275,0000.24%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 14,900,000$8,493,0000.12%
View complete list of ESPERION THERAPEUTICS INC NE shareholders